Cargando…

Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study

BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication u...

Descripción completa

Detalles Bibliográficos
Autores principales: Wikman, Anna, Hovén, Emma, Alvariza, Anette, Lövgren, Malin, Kreicbergs, Ulrika, Skoglund, Charlotte, Fransson, Emma, Ljungman, Gustaf, Ljung, Rickard, Ljungman, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678086/
https://www.ncbi.nlm.nih.gov/pubmed/35474312
http://dx.doi.org/10.1002/cam4.4780
_version_ 1784833917536174080
author Wikman, Anna
Hovén, Emma
Alvariza, Anette
Lövgren, Malin
Kreicbergs, Ulrika
Skoglund, Charlotte
Fransson, Emma
Ljungman, Gustaf
Ljung, Rickard
Ljungman, Lisa
author_facet Wikman, Anna
Hovén, Emma
Alvariza, Anette
Lövgren, Malin
Kreicbergs, Ulrika
Skoglund, Charlotte
Fransson, Emma
Ljungman, Gustaf
Ljung, Rickard
Ljungman, Lisa
author_sort Wikman, Anna
collection PubMed
description BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication use in parents of adolescent survivors of cancer (n = 2323) to use in parents of cancer‐free controls (n = 20,868). Cox proportional hazards models, adjusted for cancer diagnostic group, parents' age, country of birth, education level, marital status and previous mental health problems estimated the risk of use from the time of the cancer diagnosis up to 2 years later. RESULTS: During the first 6 months after the cancer diagnosis, both mothers and fathers had an increased risk of use of anxiolytics (mothers: HR(adj) 1.71, 95% CI 1.30–2.25; fathers: HR(adj) 1.57, 95% CI 1.10–2.45) and hypnotics/sedatives (mothers: HR(adj) 1.53, 95% CI 1.23–1.90; fathers: HR(adj) 1.32, 95% CI 1.00–1.75). For fathers with a prescription of psychotropic medication during the first 6 months after the cancer diagnosis, the risk remained increased after 6 months (HR(adj) 1.66, 95% CI 1.04–2.65). From 6 months after the cancer diagnosis, only the risk of antidepressant use among mothers was increased (HR(adj) 1.38, 95% CI 1.08–1.76). Risk factors included being divorced/widowed, born in a non‐Nordic country, older age and having had previous mental health problems. CONCLUSION: Our study results show that during the immediate post‐diagnostic phase, mothers and fathers of survivors of adolescent cancer are at increased risk of use of anxiolytics and sedatives, whereas only mothers are at increased risk of antidepressant use from 6 months until 2 years after the diagnosis. Further, previous mental health problems were shown to be the strongest risk factor for psychotropic medication use in both mothers and fathers, pointing to the particular vulnerability of these parents.
format Online
Article
Text
id pubmed-9678086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96780862022-11-22 Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study Wikman, Anna Hovén, Emma Alvariza, Anette Lövgren, Malin Kreicbergs, Ulrika Skoglund, Charlotte Fransson, Emma Ljungman, Gustaf Ljung, Rickard Ljungman, Lisa Cancer Med Research Articles BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication use in parents of adolescent survivors of cancer (n = 2323) to use in parents of cancer‐free controls (n = 20,868). Cox proportional hazards models, adjusted for cancer diagnostic group, parents' age, country of birth, education level, marital status and previous mental health problems estimated the risk of use from the time of the cancer diagnosis up to 2 years later. RESULTS: During the first 6 months after the cancer diagnosis, both mothers and fathers had an increased risk of use of anxiolytics (mothers: HR(adj) 1.71, 95% CI 1.30–2.25; fathers: HR(adj) 1.57, 95% CI 1.10–2.45) and hypnotics/sedatives (mothers: HR(adj) 1.53, 95% CI 1.23–1.90; fathers: HR(adj) 1.32, 95% CI 1.00–1.75). For fathers with a prescription of psychotropic medication during the first 6 months after the cancer diagnosis, the risk remained increased after 6 months (HR(adj) 1.66, 95% CI 1.04–2.65). From 6 months after the cancer diagnosis, only the risk of antidepressant use among mothers was increased (HR(adj) 1.38, 95% CI 1.08–1.76). Risk factors included being divorced/widowed, born in a non‐Nordic country, older age and having had previous mental health problems. CONCLUSION: Our study results show that during the immediate post‐diagnostic phase, mothers and fathers of survivors of adolescent cancer are at increased risk of use of anxiolytics and sedatives, whereas only mothers are at increased risk of antidepressant use from 6 months until 2 years after the diagnosis. Further, previous mental health problems were shown to be the strongest risk factor for psychotropic medication use in both mothers and fathers, pointing to the particular vulnerability of these parents. John Wiley and Sons Inc. 2022-04-26 /pmc/articles/PMC9678086/ /pubmed/35474312 http://dx.doi.org/10.1002/cam4.4780 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Wikman, Anna
Hovén, Emma
Alvariza, Anette
Lövgren, Malin
Kreicbergs, Ulrika
Skoglund, Charlotte
Fransson, Emma
Ljungman, Gustaf
Ljung, Rickard
Ljungman, Lisa
Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title_full Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title_fullStr Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title_full_unstemmed Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title_short Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
title_sort psychotropic medication use in parents of survivors of adolescent cancer: a register‐based cohort study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678086/
https://www.ncbi.nlm.nih.gov/pubmed/35474312
http://dx.doi.org/10.1002/cam4.4780
work_keys_str_mv AT wikmananna psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT hovenemma psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT alvarizaanette psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT lovgrenmalin psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT kreicbergsulrika psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT skoglundcharlotte psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT franssonemma psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT ljungmangustaf psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT ljungrickard psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy
AT ljungmanlisa psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy